Nadda expressed his concern about growing incidence of Non-Communicable Diseases and the importance of awareness regarding healthy diet and lifestyle
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
These abstracts report on the company's three lead drug candidates, including olverembatinib
Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
Establishing Asymchem’s first manufacturing footprint in Europe
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Subscribe To Our Newsletter & Stay Updated
